Dermatologic surgery during the COVID-19 pandemic: Experience of a large academic center - 10/03/21
Doi : 10.1016/j.jaad.2020.12.003
Michael W. Tee, MD, PhD a, Claire Stewart, BS a, Saud Aliessa, MD b, Max Polansky, MD a, Kalee Shah, MD a, Tatyana Petukhova, MD a, Anthony Rossi, MD b, Shari R. Lipner, MD, PhD a, Kira Minkis, MD, PhD a, ⁎ 
a Department of Dermatology, Weill Cornell Medicine, New York, New York
b Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
∗Correspondence to: Kira Minkis, MD, PhD, 1305 York Ave, 9th Floor, New York, NY 100211305 York Ave9th FloorNew YorkNY10021
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Key words : coronavirus, COVID-19, dermatology surgery, melanoma, Merkel cell carcinoma, Mohs, personal protective equipment, prevention, public health, technology, telemedicine
| Funding sources: None. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 4
P. 1094-1096 - avril 2021 Retour au numéro
Article précédent
- Mycophenolate mofetil for the treatment of cutaneous lichen planus: A retrospective case series
- Matthew L. Hrin, Arjun M. Bashyam, William W. Huang, Steven R. Feldman
- The impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: A single institution experience
- Adrienne B. Shannon, Cimarron E. Sharon, Richard J. Straker, John T. Miura, Michael E. Ming, Emily Y. Chu, Giorgos C. Karakousis
Bienvenue sur EM-consulte, la référence des professionnels de santé.